The University of Virginia is a public research university in Charlottesville, Virginia, founded in 1819 by Thomas Jefferson. It is the flagship university of Virginia and home to the Academical Village, a UNESCO World Heritage Site.

During the past decade, University of Virginia conducted 515 clinical trials. In the 10-year time frame, 515 clinical trials started and 206 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 250 clinical trials started and 112 clinical trials were completed. i.e. 44.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Virginia" #1 sponsor was "University of Virginia" with 239 trials, followed by "InSightec" with 15 trials sponsored, "Edwards Lifesciences" with 14 trials sponsored, "Janssen Research & Development, LLC" with 14 trials sponsored and "Craig L Slingluff, Jr" with 14 trials sponsored. Other sponsors include 563 different institutions and companies that sponsored additional 354 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Virginia" #1 collaborator was "University of Virginia" with 37 trials as a collaborator, "National Cancer Institute (NCI)" with 32 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 29 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 22 trials as a collaborator and "Merck Sharp & Dohme LLC" with 16 trials as a collaborator. Other collaborators include 728 different institutions and companies that were collaborators in the rest 401 trials.

According to Clinical.Site data, the most researched conditions in "University of Virginia" are "Melanoma" (15 trials), "Type 1 Diabetes" (13 trials), "Breast Cancer" (12 trials), "Diabetes Mellitus, Type 1" (12 trials) and "Heart Failure" (12 trials). Many other conditions were trialed in "University of Virginia" in a lesser frequency.

Most popular intervention types in "University of Virginia" are "Drug" (392 trials), "Device" (199 trials), "Other" (151 trials), "Procedure" (76 trials) and "Biological" (65 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (98 trials), "Bevacizumab" (12 trials), "placebo" (11 trials), "Gemcitabine" (10 trials) and "Paclitaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "University of Virginia" are 781 trials for "All" genders, 61 trials for "Female" genders and 17 trials for "Male" genders.

Currently, there are 276 active trials in "University of Virginia". 6 are not yet recruiting, 161 are recruiting, 98 are Active, not recruiting, and 11 are Enrolling by invitation. In total, there were 401 completed trials in University of Virginia, 2 suspended trials, and 81 terminated clinical trials to date.

Out of the total trials that were conducted in University of Virginia, 90 "Phase 1" clinical trials were conducted, 202 "Phase 2" clinical trials and 167 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 31 trials, and there were also 276 trials that are defined as “Not Applicable".

University of Virginia has several departments that took part in Clinical trials: "University of Virginia Center for Diabetes Technology" - 43 trials, "University of Virginia, Dept. of Psychiatry and Neurobehavioral Sciences" - 7 trials, "University of Virginia General Clinical Research Center" - 6 trials, "University of Virginia - Nephrology Clinical Research Center" - 6 trials, "UVA Health System Division of Hematology & Oncology" - 4 trials, "University of Virginia School of Medicine-Pediatrics-Site Number:840078" - 4 trials, "University of Virginia Health Systems - Department of Neurological Surgery" - 4 trials, "University of Virginia - Department of Ophthalmology" - 4 trials, "University of Virginia - Acute Care Surgery" - 4 trials, "University of Virginia Comprehensive Epilepsy Program" - 4 trials, "University of Virginia, Department of Neurology" - 3 trials, "University of Virginia, Center for Psychiatric Clinical Research" - 3 trials